Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000057

Options or other derivatives

  • Chief Medical Officer acquired 248,618 shares (grant or award)
  • Chief Medical Officer returned 372,925 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Aranda Richard · Chief Medical Officer

Table II: Derivative

12 lines
Date Transaction Shares Owned after D/I
2023-05-05 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −45,000 0 D
2023-05-05 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −13,750 0 D
2023-05-05 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −34,175 0 D
2023-05-05 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −60,000 0 D
2023-05-05 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −30,000 0 D
2023-05-05 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −190,000 0 D
2023-05-05 Grant or award : show line 7 in the form Stock Option (Right to Buy) +30,000 30,000 D
2023-05-05 Grant or award : show line 8 in the form Stock Option (Right to Buy) +9,167 9,167 D
Loading xslF345X04/wf-form4_168366370450924.xml…